SCHEMBL19959936

SCHEMBL19959936

O=P(c1ccccc1)(c1ccc2ccc3ccccc3c2c1)c1ccc2c3ccccc3n3c4ccccc4nc3c2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.42
MAPT P10636 6/20 0.42
POLB P06746 2/20 0.42
HSD17B10 Q99714 2/20 0.42
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42
HPGD P15428 6/20 0.41
ALDH1A1 P00352 6/20 0.41
KMT2A Q03164 6/20 0.40
MEN1 O00255 4/20 0.40
CAMKK1 Q8N5S9 2/20 0.38
CAMKK2 Q96RR4 2/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CASP1 P29466 1/20 0.38
CYP2C19 P33261 1/20 0.38
CASP7 P55210 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
BCL2 P10415 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19928984 0.95 KDM4E (0.46) KDM4EMAPTPOLBHSD17B10LMNA
SCHEMBL19959803 0.94 KDM4E (0.41) KDM4EMAPTPOLBHSD17B10LMNA
SCHEMBL19959943 0.94 KDM4E (0.41) KDM4EMAPTPOLBHSD17B10LMNA
SCHEMBL19959886 0.93 KDM4E (0.39) KDM4EMAPTPOLBHSD17B10LMNA
SCHEMBL19959920 0.93 KDM4E (0.38) KDM4EMAPTPOLBHSD17B10LMNA
SCHEMBL19959913 0.92 KDM4E (0.37) KDM4EMAPTPOLBHSD17B10LMNA
SCHEMBL20276021 0.92 KDM4E (0.43) KDM4EMAPTPOLBHSD17B10LMNA
SCHEMBL17403757 0.92 KDM4E (0.47) KDM4EMAPTPOLBHSD17B10LMNA
SCHEMBL17403756 0.92 KDM4E (0.47) KDM4EMAPTPOLBHSD17B10LMNA
SCHEMBL17403766 0.91 KDM4E (0.42) KDM4EMAPTPOLBHSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2020-06-30 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 KDM4E 1997/4885MAPT 1310/4885POLB 2517/4885
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 KDM4E 1997/4885MAPT 1310/4885POLB 2517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.